SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,322,444 | -66.1% | 1,327,591 | -22.6% | 0.01% | -65.4% |
| Q2 2023 | $80,699,292 | +16.2% | 1,716,268 | +3.7% | 0.03% | +13.0% |
| Q1 2023 | $69,431,309 | +137948.1% | 1,654,700 | +25.5% | 0.02% | +53.3% |
| Q4 2022 | $50,295 | -99.9% | 1,318,734 | +22.6% | 0.02% | -6.2% |
| Q3 2022 | $42,128,000 | +99.8% | 1,075,765 | +64.8% | 0.02% | +100.0% |
| Q2 2022 | $21,088,000 | +272.3% | 652,897 | +281.7% | 0.01% | +300.0% |
| Q1 2022 | $5,664,000 | -27.9% | 171,030 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $7,858,000 | -13.4% | 184,685 | -9.9% | 0.00% | -33.3% |
| Q3 2021 | $9,078,000 | -57.1% | 204,866 | -45.0% | 0.00% | -57.1% |
| Q2 2021 | $21,150,000 | +75.8% | 372,311 | +131.6% | 0.01% | +75.0% |
| Q1 2021 | $12,032,000 | -28.2% | 160,772 | -17.0% | 0.00% | -33.3% |
| Q4 2020 | $16,766,000 | +32.6% | 193,762 | -6.4% | 0.01% | +20.0% |
| Q3 2020 | $12,643,000 | +134.9% | 206,918 | +59.8% | 0.01% | +150.0% |
| Q2 2020 | $5,383,000 | +53.1% | 129,446 | +5.8% | 0.00% | 0.0% |
| Q1 2020 | $3,515,000 | -62.7% | 122,349 | -6.2% | 0.00% | -33.3% |
| Q4 2019 | $9,416,000 | -46.4% | 130,444 | +4.3% | 0.00% | -57.1% |
| Q3 2019 | $17,555,000 | -21.4% | 125,115 | +2.6% | 0.01% | -22.2% |
| Q2 2019 | $22,334,000 | +17.8% | 121,997 | +2.3% | 0.01% | +12.5% |
| Q1 2019 | $18,964,000 | +81.6% | 119,222 | +9.3% | 0.01% | +60.0% |
| Q4 2018 | $10,441,000 | -4.6% | 109,054 | +40.7% | 0.01% | +25.0% |
| Q3 2018 | $10,941,000 | +24.1% | 77,483 | +37.5% | 0.00% | 0.0% |
| Q2 2018 | $8,818,000 | +18.1% | 56,354 | +21.6% | 0.00% | +33.3% |
| Q1 2018 | $7,468,000 | +54.6% | 46,362 | +58.1% | 0.00% | +50.0% |
| Q4 2017 | $4,829,000 | – | 29,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |